Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

D. Anker, Stefan; Comín Colet, Josep; Filippatos, Gerasimos; Willenheimer, Ronnie; Dickstein, Kenneth; Drexler, Helmut; F. Lüscher, Thomas; Ya. Bart, B.; Banasiak, Waldemar; Niegowska, Joanna; Kirwan, Bridget‐Anne; Mori, Claudio; Rothe, B.; Pocock, Stuart; A. Poole‐Wilson, Philip; Ponikowski, Piotr

doi:10.1056/nejmoa0908355

Public

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

Published in New England Journal of Medicine • Nov 17, 2009

Authors:

Stefan D. Anker

Josep Comín Colet

Gerasimos Filippatos

Abstract

BACKGROUND: Iron deficiency may impair aerobic performance. This study aimed to determine whether treatment with intravenous iron (ferric carboxymaltose) would improve symptoms in patients who had heart failure, reduced left ventricular ejection fraction, and iron deficiency, either with or without ...

Subject

Medicine

Heart failure

Iron deficiency

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!